Brain Cancer Trial, Recruiting NCT02417324 Sponsor: Universitätsklinikum Hamburg-Eppendorf Condition: Brain Cancer
Back to Brain Cancer

Brain Cancer Trial, Recruiting

NCT02417324
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with one of the specific brain or spinal cord tumour types this trial covers (please confirm the exact tumour types with the trial site)
  • Your tumour can be located anywhere in the body where these tumour types occur
  • You can be at any stage of your illness
  • Your diagnosis was first made after 1st January 2012
  • You were not able to join, or chose not to join, another clinical trial for the same diagnosis (for example, because you were not eligible, the trial was not available in your country, or you personally decided not to participate)
  • Special note: for certain specific tumour types (ependymoma WHO Grade I, pineal parenchymal tumour of intermediate differentiation, and papillary tumour of the pineal region), you must have been first diagnosed before your 18th birthday to be eligible (confirm with trial site)
  • You are able and willing to give written permission for your data and tumour samples to be shared, in line with the laws of your country
  • The necessary ethical approvals required by your country are in place

Who may not be able to join:

  • You are currently enrolled in another clinical trial for the same diagnosis (note: a relapse, or return of the illness, is considered a new diagnosis for this purpose)
  • The required ethical committee approval is not in place

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Stefan Rutkowski, Prof., Universitätsklinikum Hamburg-Eppendorf

Phone: +49-40-7410

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Universitätsklinikum Hamburg-Eppendorf
Registry
ClinicalTrials.gov
Start date
1 January 2015
Est. completion
1 December 2029

Where this trial is recruiting

🇩🇪 Germany

Primary endpoints

Event free survival

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov